Silvia Mari obtained her PhD in Chemistry in 2006 at the Universidad Autonoma of Madrid (Spain) under the direction of Prof. Jesus Jimenez-Barbero. She focused her research in small molecules conformational research and protein-ligand interaction studies by Nuclear Magnetic Resonance (NMR). Particularly, in collaboration with the organic synthesis and computational chemistry partners, she focused her investigation in NMR structure-based drug design of glycomimetics of biological interest.
After a first post-doc period at the University of Milan, she was appointed at Dulbecco Telethon Institute c/o S. Raffaele Scientific Institute in Milan (Italy). Her research focused on development of advanced methods for monitoring in-vivo ligand-target interaction and structure determination and validation by NMR and implementation and application of NMR metabolomic in collaboration with different researching groups. She was involved in developing new computational tools to assist spectroscopist in metabolite assignment and mixture analysis (in collaboration with CCPN -The Collaborative Computing Project for NMR) and she has now ongoing a collaboration with Mestrelab Research Company. Since 2007, she was involved in several grant applications both at national and international levels. Since 2009 she is involved in paper review in the field of NMR and metabolomics and has joint the Editorial Board of two international journals. She has published about 20 scientific publications (see her profile on Google Scholar).
In 2007 she was granted for the attendance to the course “Management and Enhancement of Results in Academia and Industrial Research” hold by Politecnico University of Milan and which topics included general tools for management like business planning, budget management and patent issue. Moreover, in 2011 she founded her own company called R4R (www.research4rent.com) with the aim to help connections between Pharma and Biotech companies and scientific excellences of leading Research Centers around the world in order to build synergistic partnerships for R&D applications.